https://progdd.com/%F0%9F%93%9A+Fundamentals/_aboutFundamentalshttps://progdd.com/%F0%9F%8D%8B+Squeeze/_aboutSqueezehttps://progdd.com/Companies/Medimetricshttps://progdd.com/Companies/Biora+Therapeuticshttps://progdd.com/%F0%9F%A4%9D+Collaborations/Terry+Research+Labhttps://progdd.com/%F0%9F%A4%9D+Collaborations/Ionis+Pharmaceuticals+Collaborationhttps://progdd.com/Companies/Ionis+Pharmaceuticalshttps://progdd.com/%F0%9F%A4%94+Speculation/_aboutSpeculationhttps://progdd.com/%F0%9F%8E%93+Research/A+Novel+Capsule-Delivered+Enteric+Drug-Injection+Device+for+Delivery+of+Systemic+Biologicshttps://progdd.com/%F0%9F%8E%93+Research/_aboutResearchhttps://progdd.com/Companies/Athyrium+Capital+Managementhttps://progdd.com/%F0%9F%8E%93+Research/Novel+and+Emerging+Therapies+for+Inflammatory+Bowel+Diseasehttps://progdd.com/%F0%9F%8E%93+Research/An+Overview+of+Robotic+Capsules+for+Drug+Delivery+to+the+Gastrointestinal+Tracthttps://progdd.com/People/Clinical+Advisory+Board/Anthony+Lembohttps://progdd.com/People/Clinical+Advisory+Board/William+Cheyhttps://progdd.com/People/Clinical+Advisory+Board/Satish+Raohttps://progdd.com/People/Clinical+Advisory+Board/S%C3%A9verine+Vermeirehttps://progdd.com/People/Clinical+Advisory+Board/Geert+D%E2%80%99Haenshttps://progdd.com/People/Clinical+Advisory+Board/Bruce+Sandshttps://progdd.com/People/Board/Lynne+Powellhttps://progdd.com/People/Board/Brian+Kotzinhttps://progdd.com/People/Board/Surbhi+Sarnahttps://progdd.com/People/Board/Jill+Howehttps://progdd.com/People/Board/Jeffrey+Alterhttps://progdd.com/People/Board/Jeffrey+Ferrellhttps://progdd.com/People/Executive+Team/Sharat+Singhhttps://progdd.com/People/Executive+Team/Chris+Wahlhttps://progdd.com/People/Executive+Team/Robyn+Hattonhttps://progdd.com/People/Executive+Team/Paul+Shabramhttps://progdd.com/People/Executive+Team/Eric+d%E2%80%99Esparbeshttps://progdd.com/People/Executive+Team/Clarke+Neumannhttps://progdd.com/People/Executive+Team/Adi+Mohantyhttps://progdd.com/People/Former+Employees/Jeff+Shimizuhttps://progdd.com/%F0%9F%A4%94+Speculation/_thesishttps://progdd.com/%F0%9F%A4%94+Speculation/_importantDateshttps://progdd.com/%F0%9F%90%B8+abouthttps://progdd.com/%E2%9A%A1+Risks/Insider+Ownershiphttps://progdd.com/%F0%9F%8E%93+Research/A+Multidisciplinary+International+Consensus+Initiative+to+Develop+a+Core+Outcome+Set+for+Randomized+Controlled+Trials+in+Inflammatory+Bowel+Diseasehttps://progdd.com/%F0%9F%8E%93+Research/Device+Development+for+Long-Term+Systemic+Oral+Biologic+Drug+Deliveryhttps://progdd.com/%F0%9F%8D%8B+Squeeze/_aboutLiveInterestShortDatahttps://progdd.com/%F0%9F%8E%93+Research/Current+Trends+in+IBD%E2%80%94Development+of+Mucosal-Based+Biomarkers+and+a+Novel+Minimally+Invasive+Recoverable+Sampling+Systemhttps://progdd.com/People/Others/Takeda/Vijay+Yajnikhttps://progdd.com/People/Others/Terry+Research+Lab/Benjamin+Wankumhttps://progdd.com/People/Others/Terry+Research+Lab/Benjamin+Terryhttps://progdd.com/Companies/Takedahttps://progdd.com/%F0%9F%8E%93+Research/Development+of+a+Novel+Drug+Delivery+System+to+Deliver+Drugs+Directly+to+the+Colonic+Mucosahttps://progdd.com/People/Former+Employees/Emil+Chaunghttps://progdd.com/%F0%9F%93%8C+Presentations/A+Novel+Method+for+Collecting+Microbiome+Specimenshttps://progdd.com/People/Others/Biora+Therapeutics/Shaoying+Nikki+Leehttps://progdd.com/%E2%9A%A1+Risks/Dilutionhttps://progdd.com/%E2%9A%A1+Risks/Reduced+Disclosure+Requirementshttps://progdd.com/%F0%9F%93%9A+Fundamentals/Pipeline/DDShttps://progdd.com/%F0%9F%93%9A+Fundamentals/Pipeline/PGN-OB1https://progdd.com/%F0%9F%93%9A+Fundamentals/Pipeline/PGN-600https://progdd.com/%F0%9F%93%9A+Fundamentals/Pipeline/PGN-001https://progdd.com/%F0%9F%93%9A+Fundamentals/Pipeline/PGN-OB2https://progdd.com/%F0%9F%93%9A+Fundamentals/Pipeline/OBDShttps://progdd.com/%F0%9F%93%9A+Fundamentals/Pipeline/Targeted+Therapeutics+Pipelinehttps://progdd.com/%F0%9F%93%9A+Fundamentals/Pipeline/Systemic+Therapeutics+Pipelinehttps://progdd.com/People/Former+Employees/Harry+Styllihttps://progdd.com/%F0%9F%8E%93+Research/Devices+for+drug+delivery+in+the+gastrointestinal+tracthttps://progdd.com/%F0%9F%93%8C+Presentations/Development+of+ex-vivo+and+in-vivo+models+to+assess+the+performance+of+an+oral+biotherapeutic+delivery+system+(OBDS)+capsulehttps://progdd.com/%F0%9F%93%8C+Presentations/Assessing+the+performance+of+an+oral+biotherapeutic+delivery+system+(OBDS)+using+intra-duodenal+endoscopy+delivery+in+Yucatan+minipigshttps://progdd.com/People/Others/Biora+Therapeutics/Cheryl+Storkhttps://progdd.com/People/Others/Biora+Therapeutics/Nelson+Quintanahttps://progdd.com/People/Others/Biora+Therapeutics/Jeffrey+Smithhttps://progdd.com/%F0%9F%A4%94+Speculation/Analyst+Reports/Preclinical+Data+Highlight+Efforts+Towards+Prepping+OBDS+for+Primetimehttps://progdd.com/%F0%9F%A4%94+Speculation/Analyst+Reports/_analystReportIndexhttps://progdd.com/Companies/H.C.+Wainwright+%26+Co.https://progdd.com/%F0%9F%A4%94+Speculation/Analyst+Reports/BTIG+Assumes+Biora+Therapeutics+at+Buy%2C+Announces+Price+Target+of+%244https://progdd.com/People/Others/_Analysts/Julian+Harrisonhttps://progdd.com/People/Others/_Analysts/Joseph+Pantginishttps://progdd.com/Companies/BTIGhttps://progdd.com/%F0%9F%93%9A+Fundamentals/Pipeline/RSShttps://progdd.com/People/Former+Employees/Ryan+Joneshttps://progdd.com/People/Former+Employees/Mitchell+Joneshttps://progdd.com/Companies/Micropharmahttps://progdd.com/Companies/Interface+Therapeutics+Inc.https://progdd.com/Companies/Finch+Therapeuticshttps://progdd.com/%F0%9F%93%9A+Fundamentals/Conferences/PDA+Universe+of+Pre-Filled+Syringes+and+Injection+Devices+Conferencehttps://progdd.com/%F0%9F%93%9A+Fundamentals/Organizations/Controlled+Release+Societyhttps://progdd.com/%F0%9F%93%9A+Fundamentals/Organizations/Parenteral+Drug+Associationhttps://progdd.com/%F0%9F%93%9A+Fundamentals/Glossary/Crohn's+Diseasehttps://progdd.com/%F0%9F%93%9A+Fundamentals/Glossary/Antisensehttps://progdd.com/%F0%9F%93%9A+Fundamentals/Glossary/Core+Outcome+Measures+in+Effectiveness+Trialshttps://progdd.com/%F0%9F%93%9A+Fundamentals/Glossary/Ulcerative+Colitishttps://progdd.com/%F0%9F%93%9A+Fundamentals/Glossary/Tumor+Necrosis+Factorhttps://progdd.com/%F0%9F%93%9A+Fundamentals/Glossary/Translational+Sciencehttps://progdd.com/%F0%9F%93%9A+Fundamentals/Glossary/TPPhttps://progdd.com/%F0%9F%93%9A+Fundamentals/Glossary/TNF+Inhibitorhttps://progdd.com/%F0%9F%93%9A+Fundamentals/Glossary/TAMhttps://progdd.com/%F0%9F%93%9A+Fundamentals/Glossary/SCIDDhttps://progdd.com/%F0%9F%93%9A+Fundamentals/Glossary/New+Drug+Applicationhttps://progdd.com/%F0%9F%93%9A+Fundamentals/Glossary/Preeclampsiahttps://progdd.com/%F0%9F%93%9A+Fundamentals/Glossary/Net+Present+Valuehttps://progdd.com/%F0%9F%93%9A+Fundamentals/Glossary/JAK-STAT+Signaling+Pathwayhttps://progdd.com/%F0%9F%93%9A+Fundamentals/Glossary/Inflammatory+Bowel+Diseasehttps://progdd.com/%F0%9F%93%9A+Fundamentals/Glossary/Intellectual+Propertyhttps://progdd.com/%F0%9F%93%9A+Fundamentals/Glossary/Janus+Kinasehttps://progdd.com/%F0%9F%93%9A+Fundamentals/Glossary/Gastroenterologyhttps://progdd.com/%F0%9F%93%9A+Fundamentals/Glossary/Good+Manufacturing+Practicehttps://progdd.com/%F0%9F%93%9A+Fundamentals/Glossary/IDMPhttps://progdd.com/%F0%9F%93%9A+Fundamentals/Glossary/FIHhttps://progdd.com/%F0%9F%93%9A+Fundamentals/Glossary/Cytokinehttps://progdd.com/%F0%9F%93%9A+Fundamentals/Glossary/Combination+Productshttps://progdd.com/%F0%9F%93%9A+Fundamentals/Glossary/BLAhttps://progdd.com/%F0%9F%93%9A+Fundamentals/Pipeline/Preecludiahttps://progdd.com/%F0%9F%93%9A+Fundamentals/Organizations/Crohn's+and+Colitis+Foundationhttps://progdd.com/People/Others/Biora+Therapeutics/Pejman+Rahimianhttps://progdd.com/People/Former+Employees/Jacob+Casehttps://progdd.com/%F0%9F%8E%93+Research/Tofacitinib+tissue+exposure+correlates+with+endoscopic+outcomehttps://progdd.com/%F0%9F%8E%93+Research/An+increased+baseline+mucosal+TNF+burden+linked+to+adalimumab+non-responsehttps://progdd.com/%F0%9F%8E%93+Research/Safety+and+efficacy+of+combining+biologics+or+small+molecules+for+inflammatory+bowel+disease+or+immune-mediated+inflammatory+diseaseshttps://progdd.com/%F0%9F%8E%93+Research/Characterization+of+cytokine+and+drug+concentrations+in+serum%2C+mucosa+and+faeces+during+induction+treatment+of+moderate-to-severe+ulcerative+colitis+with+anti-TNF+monoclonal+antibodieshttps://progdd.com/People/Others/KU+Leuven/Bram+Verstockthttps://progdd.com/%F0%9F%8E%93+Research/Dual+Biologic+or+Small+Molecule+Therapy+for+Treatment+of+Inflammatory+Bowel+Diseasehttps://progdd.com/Companies/Novo+Nordiskhttps://progdd.com/%F0%9F%93%9A+Fundamentals/Drugs/Tofacitinibhttps://progdd.com/%F0%9F%93%9A+Fundamentals/Drugs/Semaglutidehttps://progdd.com/%F0%9F%93%9A+Fundamentals/Drugs/Liraglutidehttps://progdd.com/%F0%9F%93%9A+Fundamentals/Drugs/Infliximabhttps://progdd.com/%F0%9F%93%9A+Fundamentals/Drugs/Adalimumabhttps://progdd.com/%F0%9F%93%9A+Fundamentals/Drugs/Tirzepatidehttps://progdd.com/Companies/Eli+Lillyhttps://progdd.com/%F0%9F%93%9A+Fundamentals/Drugs/Ustekinumabhttps://progdd.com/Companies/Janssen+Pharmaceuticals